Company / Interest Expense per Share
Cardiff Oncology, Inc. Interest Expense per Share History
FY2016-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.00
FY2021
5-year range
$0.00 / $0.00
FY2017-FY2021
Trend
-76.6%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense per Share has fluctuated over the past 6 years, ranging from $-0.03 in FY2016 to $1.41 in FY2018.
Based on SEC 10-K filings.
0.00 in FY2021 with a 3-year CAGR of -96.6%.
Increased from $0.00 to $0.00 over the past 2 years.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -96.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, interest expense per share decreased 76.6% year-over-year.
- Peak interest expense per share was recorded in FY2018.
- Lowest interest expense per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $0.00 | -76.6% |
| FY2020 | $0.00 | - |
| FY2019 | $0.00 | -100.0% |
| FY2018 | $1.41 | +2485.3% |
| FY2017 | $0.05 | +295.2% |
| FY2016 | -$0.03 | -134.7% |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026